Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Jul 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Adora Life Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Adora Life Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Adora Life Science
Developer of biopharmaceutical products intended to improve the health of animals and humans. The company offers generic arthritis drugs for animals, topical treatments for osteoarthritis and related conditions in humans, enabling patients to access natural biomolecule-based alternatives to non-steroidal anti-inflammatory drugs for pain relief and healing.
- Sector
- Healthcare
- HQ
- Franklin, TN, United States
- Founded
- 2019
- Employees
- 2
- Website
- adoralifescience.com/
- Ownership
- Privately Held (backing)
Adora Life Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Adora Life Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Adora Life Science in its N-PORT filings yet. We sweep new filings monthly.